Trend — Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg (J0737) in Medicare, the United States

The full twelve-year services and payments series for this market — per-year values, with the FFS-enrollment denominator beside each.

The compound annual growth for J0737 in the United States — endpoints exclude the introduction year; an Exclude 2020–21 view drops the pandemic years too.